These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 8106772)
1. Primary prophylaxis with pyrimethamine for toxoplasmic encephalitis in patients with advanced human immunodeficiency virus disease: results of a randomized trial. Terry Beirn Community Programs for Clinical Research on AIDS. Jacobson MA; Besch CL; Child C; Hafner R; Matts JP; Muth K; Wentworth DN; Neaton JD; Abrams D; Rimland D J Infect Dis; 1994 Feb; 169(2):384-94. PubMed ID: 8106772 [TBL] [Abstract][Full Text] [Related]
2. Dapsone-pyrimethamine compared with aerosolized pentamidine as primary prophylaxis against Pneumocystis carinii pneumonia and toxoplasmosis in HIV infection. The PRIO Study Group. Girard PM; Landman R; Gaudebout C; Olivares R; Saimot AG; Jelazko P; Gaudebout C; Certain A; Boué F; Bouvet E N Engl J Med; 1993 May; 328(21):1514-20. PubMed ID: 8479488 [TBL] [Abstract][Full Text] [Related]
3. Once-weekly administration of dapsone/pyrimethamine vs. aerosolized pentamidine as combined prophylaxis for Pneumocystis carinii pneumonia and toxoplasmic encephalitis in human immunodeficiency virus-infected patients. Opravil M; Hirschel B; Lazzarin A; Heald A; Pechère M; Rüttimann S; Iten A; von Overbeck J; Oertle D; Praz G Clin Infect Dis; 1995 Mar; 20(3):531-41. PubMed ID: 7756472 [TBL] [Abstract][Full Text] [Related]
4. Aerosolized pentamidine, cotrimoxazole and dapsone-pyrimethamine for primary prophylaxis of Pneumocystis carinii pneumonia and toxoplasmic encephalitis. Antinori A; Murri R; Ammassari A; De Luca A; Linzalone A; Cingolani A; Damiano F; Maiuro G; Vecchiet J; Scoppettuolo G AIDS; 1995 Dec; 9(12):1343-50. PubMed ID: 8605054 [TBL] [Abstract][Full Text] [Related]
5. Effectiveness of twice-weekly pyrimethamine-sulfadoxine as primary prophylaxis of Pneumocystis carinii pneumonia and toxoplasmic encephalitis in patients with advanced HIV infection. Schürmann D; Bergmann F; Albrecht H; Padberg J; Wünsche T; Grünewald T; Schürmann M; Grobusch M; Vallée M; Ruf B; Suttorp N Eur J Clin Microbiol Infect Dis; 2002 May; 21(5):353-61. PubMed ID: 12072919 [TBL] [Abstract][Full Text] [Related]
6. Pyrimethamine for primary prophylaxis of toxoplasmic encephalitis in patients with human immunodeficiency virus infection: a double-blind, randomized trial. ANRS 005-ACTG 154 Group Members. Agence Nationale de Recherche sur le SIDA. AIDS Clinical Trial Group. Leport C; Chêne G; Morlat P; Luft BJ; Rousseau F; Pueyo S; Hafner R; Miro J; Aubertin J; Salamon R; Vildé JL J Infect Dis; 1996 Jan; 173(1):91-7. PubMed ID: 8537688 [TBL] [Abstract][Full Text] [Related]
7. Meta-analysis of prophylactic treatments against Pneumocystis carinii pneumonia and toxoplasma encephalitis in HIV-infected patients. Bucher HC; Griffith L; Guyatt GH; Opravil M J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Jun; 15(2):104-14. PubMed ID: 9241108 [TBL] [Abstract][Full Text] [Related]
9. Prevention of Pneumocystis carinii pneumonia and toxoplasmic encephalitis in human immunodeficiency virus infected patients: a clinical approach comparing aerosolized pentamidine and pyrimethamine/sulfadoxine. Köppen S; Grünewald T; Jautzke G; Gottschalk J; Pohle HD; Ruf B Clin Investig; 1992 Jun; 70(6):508-12. PubMed ID: 1356529 [TBL] [Abstract][Full Text] [Related]
10. Low-dose trimethoprim-sulfamethoxazole prophylaxis for toxoplasmic encephalitis in patients with AIDS. Carr A; Tindall B; Brew BJ; Marriott DJ; Harkness JL; Penny R; Cooper DA Ann Intern Med; 1992 Jul; 117(2):106-11. PubMed ID: 1351371 [TBL] [Abstract][Full Text] [Related]
11. Intermittent trimethoprim-sulfamethoxazole compared with dapsone-pyrimethamine for the simultaneous primary prophylaxis of Pneumocystis pneumonia and toxoplasmosis in patients infected with HIV. Podzamczer D; Salazar A; Jiménez J; Consiglio E; Santín M; Casanova A; Rufí G; Gudiol F Ann Intern Med; 1995 May; 122(10):755-61. PubMed ID: 7717598 [TBL] [Abstract][Full Text] [Related]
12. Twice-weekly maintenance therapy with sulfadiazine-pyrimethamine to prevent recurrent toxoplasmic encephalitis in patients with AIDS. Spanish Toxoplasmosis Study Group. Podzamczer D; Miró JM; Bolao F; Gatell JM; Cosín J; Sirera G; Domingo P; Laguna F; Santamaría J; Verdejo J Ann Intern Med; 1995 Aug; 123(3):175-80. PubMed ID: 7598298 [TBL] [Abstract][Full Text] [Related]
13. [Epidemiologic characteristics of cerebral toxoplasmosis in 399 HIV-infected patients followed between 1983 and 1994]. Bossi P; Caumes E; Astagneau P; Li TS; Paris L; Mengual X; Katlama C; Bricaire F Rev Med Interne; 1998 May; 19(5):313-7. PubMed ID: 9775164 [TBL] [Abstract][Full Text] [Related]
14. Discontinuation of primary prophylaxis for Pneumocystis carinii pneumonia and toxoplasmic encephalitis in human immunodeficiency virus type I-infected patients: the changes in opportunistic prophylaxis study. Mussini C; Pezzotti P; Govoni A; Borghi V; Antinori A; d'Arminio Monforte A; De Luca A; Mongiardo N; Cerri MC; Chiodo F; Concia E; Bonazzi L; Moroni M; Ortona L; Esposito R; Cossarizza A; De Rienzo B J Infect Dis; 2000 May; 181(5):1635-42. PubMed ID: 10823763 [TBL] [Abstract][Full Text] [Related]
16. A randomized trial of daily and thrice-weekly trimethoprim-sulfamethoxazole for the prevention of Pneumocystis carinii pneumonia in human immunodeficiency virus-infected persons. Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA). El-Sadr WM; Luskin-Hawk R; Yurik TM; Walker J; Abrams D; John SL; Sherer R; Crane L; Labriola A; Caras S; Pulling C; Hafner R Clin Infect Dis; 1999 Oct; 29(4):775-83. PubMed ID: 10589887 [TBL] [Abstract][Full Text] [Related]
17. Pneumocystis prophylaxis and survival in patients with advanced human immunodeficiency virus infection treated with zidovudine. The Zidovudine Epidemiology Group. Chaisson RE; Keruly J; Richman DD; Moore RD Arch Intern Med; 1992 Oct; 152(10):2009-13. PubMed ID: 1417373 [TBL] [Abstract][Full Text] [Related]
18. Twice-weekly pyrimethamine-sulfadoxine effectively prevents Pneumocystis carinii pneumonia relapse and toxoplasmic encephalitis in patients with AIDS. Schürmann D; Bergmann F; Albrecht H; Padberg J; Grünewald T; Behnsch M; Grobusch M; Vallée M; Wünsche T; Ruf B; Suttorp N J Infect; 2001 Jan; 42(1):8-15. PubMed ID: 11243747 [TBL] [Abstract][Full Text] [Related]
19. Increased risk of toxoplasmic encephalitis in human immunodeficiency virus-infected patients with pyrimethamine-related rash. ANRS 005-ACTG 154 Trial Group. Agence Nationale de Recherche sur le SIDA (ANRS-INSERM) and the NIAID-AIDS Clinical Trials Group. Rousseau F; Pueyo S; Morlat P; Hafner R; Chène G; Leport C; Luft BJ; Miro J; Aubertin J; Salamon R; Vildé JL Clin Infect Dis; 1997 Mar; 24(3):396-402. PubMed ID: 9114191 [TBL] [Abstract][Full Text] [Related]